New cell injection aims to free type 1 diabetes patients from insulin
Disease control
Recruiting now
This is an early safety study testing a new islet cell injection called RGB-5088 for adults with Type 1 diabetes. The main goal is to see if the treatment is safe and if it can help patients achieve better blood sugar control without severe low blood sugar events. Researchers wil…
Phase: PHASE1 • Sponsor: Hangzhou Reprogenix Bioscience, Inc • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC